Policy and Legislation
HIMSS President and CEO Hal Wolf addresses research cuts, the workforce shortage and digital health during a press conference.
The administration is decrying what it calls "hidden" prices and "opaque" pricing arrangements.
Letter to CEO Andrew Witty follows report of DOJ launching investigation into the company's billing methods.
The FTC alleges anticompetitive and unfair rebating practices that artificially inflate the list price of insulin.
Sponsors say a pathway is important because many cancers currently lack an effective screening option.
The FTC maintains that PBMs systematically prefer high list price insulin products with high rebates and fees over low list products.
HIMSS25
As health disparities continue there needs to be a new way to address DEI amid administrative changes, say HIMSS25 Health Equity Forum speakers Dr. Chris Gibbons, Greystone Group founder and CEO, and Ysabel Duron, founder and executive director of the Latino Cancer Institute.
HHS officials reportedly indefinitely postponed the CDC's Advisory Committee of Immunization Practices.
While President Trump has vowed not to touch Medicaid or Medicare, a vote is expected next week that would likely cut Medicaid.
This includes about 1,300 employees, or 10% of the workforce, at the CDC and 1,500 employees at the NIH.